SHARON WRIGHT: Open Payments
NPI 1700094463 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 74 payments from 11 companies in 2025. Trend: 2023 $1,327 · 2024 $931 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 27 | $375 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $171 |
| ABBVIE INC. | 11 | $159 |
| Neurocrine BioSciences, Inc. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Alkermes, Inc. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Lundbeck LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: REXULTI, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, INGREZZA, FANAPT, ARISTADA, AUSTEDO XR.
Industry payments across AL — which companies pay providers there.
